Unravel

ing the Complex Web Between Insomnia and Hazardous Drinking: New Study Highlights Pathways of Stress and Depression

The intersection of sleep disturbances and alcohol misuse has long perplexed clinicians, researchers, and public health officials. Clinical estimates suggest that anywhere from one-third to an astonishing 91 percent of individuals who struggle with chronic insomnia also grapple with alcohol misuse. While this profound comorbidity is well-documented, the precise mechanisms driving the cyclical relationship between sleepless nights and heavy drinking have remained difficult to isolate.

Recent research published in the journal Alcohol sheds critical new light on this dual public health challenge. Conducted by a collaborative team of investigators from The Ohio State University and the University of Kentucky, the study demonstrates that perceived stress and symptoms of depression act as pivotal mediating factors connecting insomnia and hazardous drinking. Crucially, the research reveals that the influence of these psychological factors depends entirely on the directional pathway—whether insomnia precipitates alcohol misuse or, conversely, if heavy drinking triggers the onset of sleep difficulties.

The Main Findings: Directional Pathways of Stress and Depression

To untangle the overlapping and distinct roles of stress and depression, the research team analyzed data from 405 adult volunteers. These participants were originally recruited as part of a larger, ongoing clinical initiative testing the efficacy of digital interventions for individuals experiencing both poor sleep and heavy alcohol consumption.

When evaluating the data through sophisticated statistical models, the researchers discovered that the pathway from insomnia to hazardous drinking operates primarily through perceived stress. Conversely, when the pathway is reversed—examining how alcohol misuse leads to the development of sleep disturbances—the connection is primarily mediated by depressive symptoms.

“We were most interested in how insomnia leads to drinking, and we found that seems to occur primarily through stress. But when we switched pathways, it appeared that drinking primarily led to insomnia through depression,” explained Dr. Jessica Weafer, senior author of the study and associate professor of psychiatry and behavioral health in The Ohio State University College of Medicine.

This distinction offers a groundbreaking framework for understanding a condition that often presents as a continuous, compounding loop. While stress and depression frequently overlap in clinical presentations, the research underscores that they function as distinct psychological drivers with unique implications for behavioral health.

Understanding the Methodology and Participant Demographics

The study relied on comprehensive self-reported questionnaires administered to the 405 participants. These assessments measured insomnia severity, historical and current drinking habits, levels of perceived stress, and specific symptoms of depression.

Justin Verlinden, a cognitive neuroscience PhD student at the University of Kentucky and lead author of the study, noted that the complexity of the data required advanced statistical modeling to isolate the specific contributions of stress versus depression.

“There are so many different pathways that could explain insomnia and alcohol use. We wanted to connect the dots and see if there’s anything there,” Verlinden stated. “When you put both stress and depression in the same models, that’s where we get unique findings, even though there are a lot of shared characteristics between stress and depression.”

The measurement scales were specifically chosen to parse these overlapping conditions. The perceived stress scale evaluates the degree to which an individual views life circumstances as overwhelming or unpredictable, whereas the depression scale measures behavioral and emotional indicators such as hopelessness, persistent low mood, feelings of isolation, and a lack of pleasure.

By analyzing these variables simultaneously, the researchers could isolate the unique variance attributable to stress—beyond any symptoms shared with depression—when predicting heavy alcohol consumption. Likewise, they successfully isolated the unique variance attributable to depression when evaluating how alcohol use predicts the subsequent onset of insomnia. Both factors emerged as partial indirect paths, indicating that while stress and depression play vital roles, additional biological, environmental, and behavioral variables also contribute to the overall relationship.

The Broad Societal and Health Toll of Comorbid Insomnia and AUD

The clinical implications of this research extend far beyond academic interest. Both chronic insomnia and hazardous drinking carry substantial societal, economic, and personal costs. Individuals suffering from these overlapping conditions frequently experience significant upheaval, including missed workdays, reduced on-the-job productivity, and strained interpersonal relationships.

From a physiological standpoint, chronic insomnia is a known independent risk factor for a host of severe long-term health complications, including cardiovascular disease, metabolic disorders, and neurodegenerative conditions such as Alzheimer’s disease. Meanwhile, alcohol use disorder (AUD) is formally characterized by continued consumption despite clear negative consequences, such as physical illness, legal troubles, and dangerous behaviors like driving while intoxicated.

Dr. Weafer, whose academic career has focused heavily on identifying the underlying risks and vulnerabilities associated with problem drinking, emphasized the striking prevalence of sleep disturbances among individuals diagnosed with AUD.

“The number of people with AUD who also have insomnia is very, very high. It’s striking, and important,” Weafer noted. This clinical reality has driven her and her colleagues to expand their research focus, ensuring that future interventions do not treat sleep pathology and substance use in isolation from one another.

Implications for Clinical Treatment and Behavioral Interventions

The identification of these distinct mediating pathways holds profound promise for the future of clinical therapeutics. Traditional treatment models for co-occurring sleep and substance use disorders have often relied on sequential therapies or have treated the conditions as independent entities. However, these new findings suggest that tailored, mechanism-specific interventions could dramatically improve patient outcomes.

“Identifying these types of mediating factors can have important treatment implications,” Weafer explained. “If people who have insomnia are experiencing a lot of stress, then if we can target the stress, that might reduce the likelihood that their insomnia would lead to heavy drinking. That’s the long-term ideal, or hope, that this work could have an impact on treatment.”

By addressing perceived stress early in patients presenting with insomnia, clinicians may effectively short-circuit the behavioral trajectory that leads many individuals to self-medicate with alcohol. Conversely, for patients presenting with alcohol misuse who subsequently develop severe sleep complaints, therapeutic modalities that specifically target depressive symptoms may prove more effective in restoring healthy sleep architecture and preventing relapse.

This proactive approach aligns closely with ongoing clinical trials being conducted by the research team. In addition to their observational analyses, the investigators have been actively testing the clinical efficacy of a digital cognitive behavioral therapy for insomnia (CBT-I) intervention known as SHUTi (Sleep Healthy Using the internet).

A pilot study published by the research team in December 2023 demonstrated encouraging results, showing that the digital SHUTi platform was highly effective at reducing insomnia severity in heavy drinkers—even in the absence of explicit, concurrent directives aimed at curbing alcohol consumption. This suggests that stabilizing a patient’s sleep patterns may exert a stabilizing effect on their broader behavioral health profile.

Chronology of the Research and Future Directions

The publication of this study in the journal Alcohol represents a major milestone in a multi-stage research initiative supported by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), alongside institutional support from the University of Kentucky.

However, the researchers caution that the current findings represent a cross-sectional "snapshot" in time rather than a longitudinal map of how the relationship between insomnia and heavy drinking evolves across an individual’s lifespan. To bridge this gap, the research team is currently finalizing the collection of a comprehensive 12-month longitudinal dataset. This upcoming data release will allow investigators to track the temporal progression of insomnia, stress, depression, and alcohol consumption over a full year, providing unprecedented clarity on causal dynamics and long-term trajectories.

In addition to Weafer and Verlinden, the collaborative research team includes prominent academics from multiple institutions, featuring contributions from Mairead Moloney of the University of Miami, as well as Olga Vsevolozhskaya and Lauren Whitehurst of the University of Kentucky.

Conclusion and Outlook for Public Health

The convergence of sleep science and addiction research continues to reveal the intricate ways in which lifestyle, mental health, and neurobiology intersect. By demonstrating that stress mediates the path from sleeplessness to alcohol misuse—while depression mediates the reverse—this study provides actionable insights for healthcare providers, therapists, and public health strategists.

As researchers prepare to release their 12-month longitudinal findings and continue evaluating digital therapeutic tools like SHUTi, the horizon for treating co-occurring insomnia and alcohol use disorder looks increasingly personalized and precise. By targeting the specific psychological bridges that connect poor sleep to hazardous drinking, modern medicine moves one step closer to breaking a cycle that affects millions of lives worldwide.